Xconomy’s Digital Events →
Jason Rhodes, Atlas Venture partner and former CFO and president of Epizyme.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.